Lv7
4420 积分 2022-01-23 加入
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
3天前
已完结
Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial
3天前
已关闭
McArdle sign and neck flexion-induced change in central motor conduction in multiple sclerosis
13天前
已完结
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Commentary
13天前
已完结
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
14天前
已完结
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
26天前
已关闭
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
1个月前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
2个月前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
3个月前
已完结
Multiple sclerosis research in 2025: earlier diagnosis and halting progression
3个月前
已完结
皖公网安备34019202002308
